ticlopidine has been researched along with Experimental Neoplasms in 5 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In lay terms "cancers follow bleeding", which seems to be true for antithrombotic agents in general." | 2.52 | Solid cancers after antiplatelet therapy: Confirmations, controversies, and challenges. ( Cabrera-Fuentes, HA; Cherepanov, V; Kim, MH; Serebruany, VL, 2015) |
| "However, the number and size of lung metastases were reduced in treated animals when examined at the time of sacrifice." | 1.31 | Anti-angiogenic effects of the thienopyridine SR 25989 in vitro and in vivo in a murine pulmonary metastasis model. ( Bergerat, JP; Cazenave, JP; Céraline, J; Chenard, MP; Deplanque, G; Klein-Soyer, C; Mah-Becherel, MC, 2002) |
| "Pulmonary metastases with CT26 cells could be inhibited by induction of thrombocytopenia, and reconstituted by infusion of either murine or human platelets." | 1.27 | Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. ( Ambrogio, C; Coller, BS; Karpatkin, S; Pearlstein, E, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, F | 1 |
| Wang, HJ | 1 |
| Jin, YH | 1 |
| Zhang, Q | 1 |
| Wang, ZH | 1 |
| Jia, JM | 1 |
| Liu, F | 1 |
| Wang, L | 1 |
| Bao, QC | 1 |
| Li, DD | 1 |
| You, QD | 1 |
| Xu, XL | 1 |
| Denslow, A | 1 |
| Świtalska, M | 1 |
| Jarosz, J | 1 |
| Papiernik, D | 1 |
| Porshneva, K | 1 |
| Nowak, M | 1 |
| Wietrzyk, J | 1 |
| Serebruany, VL | 1 |
| Cherepanov, V | 1 |
| Cabrera-Fuentes, HA | 1 |
| Kim, MH | 1 |
| Mah-Becherel, MC | 1 |
| Céraline, J | 1 |
| Deplanque, G | 1 |
| Chenard, MP | 1 |
| Bergerat, JP | 1 |
| Cazenave, JP | 1 |
| Klein-Soyer, C | 1 |
| Karpatkin, S | 1 |
| Pearlstein, E | 1 |
| Ambrogio, C | 1 |
| Coller, BS | 1 |
1 review available for ticlopidine and Experimental Neoplasms
| Article | Year |
|---|---|
Solid cancers after antiplatelet therapy: Confirmations, controversies, and challenges.
Topics: Adenosine; Animals; Anticarcinogenic Agents; Aspirin; Blood Platelets; Carcinogenicity Tests; Clopid | 2015 |
4 other studies available for ticlopidine and Experimental Neoplasms
| Article | Year |
|---|---|
Novel Tetrahydropyrido[4,3-d]pyrimidines as Potent Inhibitors of Chaperone Heat Shock Protein 90.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P | 2016 |
Clopidogrel in a combined therapy with anticancer drugs-effect on tumor growth, metastasis, and treatment toxicity: Studies in animal models.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Clopidogrel; Fluorouracil; Humans; Male; Mice; Neo | 2017 |
Anti-angiogenic effects of the thienopyridine SR 25989 in vitro and in vivo in a murine pulmonary metastasis model.
Topics: Angiogenesis Inhibitors; Animals; Aorta; Cell Division; Clopidogrel; Disease Models, Animal; Foot; G | 2002 |
Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo.
Topics: Animals; Antibodies, Monoclonal; Aspirin; Blood Platelets; Humans; Immunologic Techniques; Lung Neop | 1988 |